Page last updated: 2024-11-08

aspartic acid and Affective Disorders

aspartic acid has been researched along with Affective Disorders in 10 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Naismith, SL2
Lagopoulos, J2
Hermens, DF2
White, D2
Duffy, SL2
Robillard, R1
Scott, EM1
Hickie, IB2
Chitty, KM1
Lee, RS1
Tickell, A1
Paquola, C1
Poletti, S1
Locatelli, C1
Falini, A1
Colombo, C1
Benedetti, F1
Dickstein, DP2
Towbin, KE2
Van Der Veen, JW2
Rich, BA1
Brotman, MA1
Knopf, L2
Onelio, L1
Pine, DS2
Leibenluft, E2
Cecil, KM1
DelBello, MP1
Sellars, MC1
Strakowski, SM1
Capizzano, AA1
Jorge, RE1
Acion, LC1
Robinson, RG1
Hamakawa, H1
Kato, T1
Murashita, J1
Kato, N1
Rasgon, NL1
Thomas, MA1
Guze, BH1
Fairbanks, LA1
Yue, K1
Curran, JG1
Rapkin, AJ1
Chouinard, G1
Beauclair, L1
Geiser, R1
Etienne, P1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain[NCT01844700]Phase 414 participants (Actual)Interventional2013-07-31Terminated (stopped due to very slow recruitment, no sufficient results)
Estrogen Use in Protection From Cognitive Decline[NCT00097058]71 participants (Anticipated)Observational2003-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Percent Weight Change Compared to Baseline Weight

(NCT01844700)
Timeframe: baseline to week 12

Interventionpercentage of weight change (Mean)
Ziprasidone11.58
Aripiprazole, Quetiapine, Risperidone5.66

BMI Percentile

(NCT01844700)
Timeframe: baseline to week 12

,
InterventionBMI percentile (Mean)
baselineweek 12 (n=1, n=2)
Aripiprazole, Quetiapine, Risperidone37.6762.5
Ziprasidone3259

BMI Z-scores

(NCT01844700)
Timeframe: baseline to week 12

,
InterventionBMI z-score (Mean)
baselineweek 12 (n=1, n=2)
Aripiprazole, Quetiapine, Risperidone-0.370.38
Ziprasidone-0.510.22

Weight Change

(NCT01844700)
Timeframe: baseline to week 12

,
Interventionlbs (Mean)
baselineweek 12 (n=1,2)
Aripiprazole, Quetiapine, Risperidone118.5141
Ziprasidone120.5151

Reviews

1 review available for aspartic acid and Affective Disorders

ArticleYear
In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review.
    Journal of magnetic resonance imaging : JMRI, 2007, Volume: 26, Issue:6

    Topics: Aspartic Acid; Brain Chemistry; Creatine; Frontal Lobe; Glutamates; Hippocampus; Humans; Image Proce

2007

Trials

3 trials available for aspartic acid and Affective Disorders

ArticleYear
Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:1

    Topics: Adolescent; Antimanic Agents; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Bipolar

2009
Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders.
    Journal of child and adolescent psychopharmacology, 2003,Winter, Volume: 13, Issue:4

    Topics: Aspartic Acid; Bipolar Disorder; Brain Chemistry; Cerebellum; Child; Family; Female; Frontal Lobe; H

2003
Proton magnetic resonance spectroscopy in youth with severe mood dysregulation.
    Psychiatry research, 2008, May-30, Volume: 163, Issue:1

    Topics: Antimanic Agents; Arousal; Aspartic Acid; Attention Deficit Disorder with Hyperactivity; Bipolar Dis

2008

Other Studies

6 other studies available for aspartic acid and Affective Disorders

ArticleYear
Delayed circadian phase is linked to glutamatergic functions in young people with affective disorders: a proton magnetic resonance spectroscopy study.
    BMC psychiatry, 2014, Dec-11, Volume: 14

    Topics: Adolescent; Adult; Aspartic Acid; Female; Glutamic Acid; Glutathione; Gyrus Cinguli; Humans; Male; M

2014
Cluster analysis reveals abnormal hippocampal neurometabolic profiles in young people with mood disorders.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Aspartic Acid; Cluster Analysis; Creatine; Female; Glutamic Acid; Hippocampus; Hu

2015
Adverse childhood experiences associate to reduced glutamate levels in the hippocampus of patients affected by mood disorders.
    Progress in neuro-psychopharmacology & biological psychiatry, 2016, 11-03, Volume: 71

    Topics: Adolescent; Adult; Adult Survivors of Child Abuse; Aspartic Acid; Creatine; Female; Glutamic Acid; G

2016
Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders.
    European archives of psychiatry and clinical neuroscience, 1998, Volume: 248, Issue:1

    Topics: Adult; Aspartic Acid; Basal Ganglia; Bipolar Disorder; Choline; Creatine; Depressive Disorder; Femal

1998
Menstrual cycle-related brain metabolite changes using 1H magnetic resonance spectroscopy in premenopausal women: a pilot study.
    Psychiatry research, 2001, Feb-28, Volume: 106, Issue:1

    Topics: Adolescent; Aspartic Acid; Brain; Creatine; Female; Frontal Lobe; Humans; Magnetic Resonance Spectro

2001
A pilot study of magnesium aspartate hydrochloride (Magnesiocard) as a mood stabilizer for rapid cycling bipolar affective disorder patients.
    Progress in neuro-psychopharmacology & biological psychiatry, 1990, Volume: 14, Issue:2

    Topics: Aspartic Acid; Calcium; Humans; Magnesium; Mood Disorders; Potassium; Research Design; Sodium

1990